Delivery Order SPE2DB24D9803-SPE2DB25FJSGX
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $12,168.60 firm fixed-price delivery order by the Defense Logistics Agency on September 5, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL. This delivery order, with an ultimate completion date of September 8, 2025, represents a discrete purchase under DMS Pharmaceutical Group's substantial single-award Indefinite Delivery Contract with the DLA valued at...
- The Defense Logistics Agency awarded a $9,450.05 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on September 16, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL with an ultimate completion date of September 17, 2025. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order with place of performance in Conshohocken, Pennsylvania. This award was made without set-aside designation,...
- The Defense Logistics Agency awarded a $8,717.20 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on August 27, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, a biologic medication used to treat inflammatory conditions. The contract carries an ultimate completion date of August 28, 2025, and will be performed at DMS Pharmaceutical Group's location in Conshohocken, Pennsylvania. This delivery order was not subject to any set-aside designation and represents a discrete...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $5,613.94 by the Defense Logistics Agency on April 21, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls. This firm fixed-price delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499.999 billion and valid through November 2026. The...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $5,273.06 by the Defense Logistics Agency (DLA) on August 26, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL. This firm fixed-price delivery order, with an ultimate completion date of August 27, 2025, was issued without a set-aside designation. The contract represents a single delivery order fulfillment under DMS Pharmaceutical...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $3,244.96 to DMS Pharmaceutical Group Inc. for the supply of HUMIRA (adalimumab) CF Pen 40 mg/0.4 mL on April 24, 2025, with an ultimate completion date of April 25, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order will be performed at the company's location in Park Ridge,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $9,958.88 on August 21, 2025, for HUMIRA (adalimumab) pens containing 40 mg/0.4 mL. The order, with an ultimate completion date of August 22, 2025, was issued by the Defense Logistics Agency under a firm fixed-price contract type with no set-aside designation. Performance of the delivery will take place in Conshohocken, Pennsylvania. This...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order award from the Defense Logistics Agency for HUMIRA (CF) Pen 40 mg/0.4 mls, valued at $5,315.34. The contract was awarded on August 6, 2025, with an ultimate completion date of August 7, 2025, and utilizes firm fixed-price pricing with no set-aside designation. This delivery order represents pharmaceutical supply to support Department of Defense healthcare...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $47,271.36 firm fixed-price order is for HUMIRA(CF) PEN 40 MG/0.4 MLS, a biologic medication used to treat various autoimmune conditions. This order is part of a larger indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA, which allows the agency...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at one thousand three hundred five dollars and two cents ($1,305.02) by the Defense Logistics Agency Troop Support Medical. This delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract to supply pharmaceutical items and medical products to support military treatment facilities worldwide. Under this particular order, DMS Pharmaceutical Group will deliver HUMIRA pens containing...
- SPE2DB24D9803Indefinite Delivery Contract
- SPE2DB24D9803-SPE2DB25FJSGXDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,056.20 to DMS Pharmaceutical Group Inc. for HUMIRA (CF) Pen 40 mg/0.4 mL on July 15, 2025, with a completion date of July 16, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected under a firm fixed-price contract type with no set-aside designation. The delivery order represents a procurement of the branded immunosuppressant medication used to treat autoimmune conditions, which aligns with the Defense Logistics Agency's mission to supply pharmaceutical products to military and federal healthcare facilities nationwide. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026. The parent IDC enables the agency to issue firm fixed-price delivery orders across a comprehensive pharmaceutical product portfolio including branded and generic prescription drugs, biologics, and medical consumables. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently securing contracts to deliver prescription medications and pharmacy services to Department of Defense healthcare sites worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 7/15/25 |